74.10
-0.05 (-0.07%)
| Penutupan Terdahulu | 74.15 |
| Buka | 74.16 |
| Jumlah Dagangan | 4,671,487 |
| Purata Dagangan (3B) | 2,829,144 |
| Modal Pasaran | 16,492,178,432 |
| Harga / Pendapatan (P/E TTM) | 29.76 |
| Harga / Pendapatan (P/E Ke hadapan) | 16.39 |
| Harga / Jualan (P/S) | 4.15 |
| Harga / Buku (P/B) | 3.31 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 3 Nov 2025 |
| Margin Keuntungan | 13.83% |
| Margin Operasi (TTM) | 22.17% |
| EPS Cair (TTM) | 2.38 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -1.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -18.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 54.80% |
| Nisbah Semasa (MRQ) | 3.24 |
| Aliran Tunai Operasi (OCF TTM) | 1.13 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 775.88 M |
| Pulangan Atas Aset (ROA TTM) | 6.92% |
| Pulangan Atas Ekuiti (ROE TTM) | 11.77% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menaik | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | Hologic, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.88 |
|
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 0.86% |
| % Dimiliki oleh Institusi | 102.61% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 90.00 (Argus Research, 21.46%) | Beli |
| Median | 78.00 (5.26%) | |
| Rendah | 76.00 (Morgan Stanley, 2.56%) | Pegang |
| 76.00 (Stephens & Co., 2.56%) | Pegang | |
| Purata | 79.14 (6.80%) | |
| Jumlah | 2 Beli, 5 Pegang | |
| Harga Purata @ Panggilan | 72.06 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Morgan Stanley | 11 Nov 2025 | 76.00 (2.56%) | Pegang | 74.60 |
| Mizuho | 23 Oct 2025 | 78.00 (5.26%) | Pegang | 73.89 |
| JP Morgan | 22 Oct 2025 | 78.00 (5.26%) | Pegang | 73.93 |
| Stephens & Co. | 22 Oct 2025 | 76.00 (2.56%) | Pegang | 73.93 |
| 18 Sep 2025 | 78.00 (5.26%) | Beli | 68.27 | |
| Leerink Partners | 21 Oct 2025 | 78.00 (5.26%) | Pegang | 73.98 |
| Evercore ISI Group | 07 Oct 2025 | 78.00 (5.26%) | Beli | 67.73 |
| Argus Research | 19 Sep 2025 | 90.00 (21.46%) | Beli | 66.33 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |